Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Acumet

Approved

STANDARD

Acumet

Aculife Healthcare Private Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 1c29bf2bfbaf5ff5
Company: Aculife Healthcare Private Limited
Type: Standard

Approval Details

Approval Id: 1c29bf2bfbaf5ff5
Drug Approval Philippines Name: Acumet
Product Name: Acumet
Registration Number: DRP-14852
Brand Name: Acumet
Generic Name: Metronidazole
Dosage Form: Solution for Intravenous Infusion.
Dosage Strength: 5 mg/mL [500 mg/100 mL (0.5% w/v)]
Manufacturer: Aculife Healthcare Private Limited
Importer: Blue Global (FZE)
Distributor: Blue Global (FZE)
Issuance Date: 24 January 2024
Expiry Date: 24 January 2029
Classification: Prescription (Rx) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

1c29bf2bfbaf5ff5

Type

Standard

Back to Philippines FDA Approvals

Acumet - Philippines FDA Drug Approval Details